NFKBIA and brain ischemia: Baicalein, a flavonoid compound, when administered during the subacute phase of brain ischemia–reperfusion injury, can suppress the NF-κB signaling pathway by reducing the phosphorylation of IκBα, thereby alleviating neuroinflammation and neuronal damage [73].